Company inventory work in the first quarter
Release time:
2020-08-14
Company Counts First Quarter Work
Proposes Second Quarter Work Requirements
News 4# October 23 , 24 , The Company successively held work analysis meetings for cement sector, pharmaceutical industry and directly affiliated enterprises to summarize the gains and losses of the first quarter work and put forward requirements for the next stage, especially the second quarter work. At the
analysis meeting, the person in charge of each enterprise reported the work situation in the first quarter in the form of PPT , focusing on analyzing the existing problems and proposing solutions and improvement plans. Chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work of each business sector one by one based on the economic and technical data of each enterprise in the first quarter, pointed out the highlights of the work, analyzed the problems and deficiencies, and put forward guidance and work requirements.
Cement Plate: Improve Operational Efficiency and Establish Competitive Advantage
In the first quarter, the overall efficiency of the two cement enterprises increased year-on-year, the overall production indicators improved, and the optimization of management institutions and positions was steadily advancing. Company leaders pointed out that the overall improvement of the national cement industry in 2018 has brought about an improvement in benefits, but because of this, the management and technical advantages of peak cement enterprises have not been fully reflected. With the progress of technology in the cement industry, enterprises continue to increase the intensity of technological transformation, the original advantages continue to reduce, and the gap with the advantages of enterprises is also widening. Therefore, the peak cement must clear ideas, strengthen management innovation and technological innovation, and strive to improve the efficiency of enterprise operation. The
meeting required the two cement enterprises to make equipment management the top priority of their work. The leaders in charge, departments and team leaders should "sink" to the production line, so as to drive the inspection workers and maintenance workers to find and solve problems in time, effectively improve the quality of inspection and equipment maintenance, and ensure the "zero defect" operation of equipment. Further strengthen the management of raw materials, to ensure the stability and reliability of the quality of raw materials, all incoming indicators must be kept in a controllable state, so as to provide guarantee for the stability of product quality; further deepen lean management, strive for excellence in every work detail, and strive to achieve every detail Optimum, so as to improve the overall operation level of the enterprise; with the country and the whole society paying attention to environmental protection, as a traditional manufacturing enterprise, it is necessary to continuously promote the creation of "green factories" and "standardized demonstration factories", and earnestly do a good job in environmental protection and safety management.
According to the specific conditions of the two enterprises, the meeting also requested Daye Peak to further speed up the handling of hazardous waste disposal and related procedures for mining in Xiyeshan Mine, and to do a solid job in environmental improvement and market control. Yunnan Jianfeng should pay close attention to mine renovation, scientific use of lignite and clay mine related work, and strengthen market management to ensure the balance and stability of production and sales.
Peak Pharmaceutical: Grasp the situation, strengthen innovation, and seek a breakthrough
In the recent period, pharmaceutical companies have made significant progress in factory management, technical research, organization optimization, and sales team construction. However, with a series of changes such as the reform of the medical system and the rectification of the pharmaceutical market, the pressure on the production and operation of enterprises has also increased. How to break through the development bottleneck is the most important problem that pharmaceutical companies urgently need to solve. The meeting requested that pharmaceutical companies should fully grasp the current situation, clarify where their current profit growth points are, where future growth points are, how to solve pain points and difficulties, and strive to achieve "curve overtaking" and seek greater development space. Meeting
requires pharmaceutical companies to fully understand the development trend of the industry brought about by the reform of the medical system, strengthen the innovation of marketing mode, management mode and incentive mechanism, increase the introduction of marketing talents, and realize the breakthrough of marketing; new product research and development and consistency evaluation should be carried out in stages on a weekly and monthly basis, set goals, continuously promote and summarize, and ensure the orderly development of the work; the selection and grafting of new development projects and new varieties should have a clear direction, and establish corresponding professional teams and responsibility assessment objectives; the management of new projects should have clear objectives and plans, strengthen management communication and coordination with cooperative enterprises, fully and effectively integrate existing resources, establish competitive advantages, and truly take the road of differentiated development.
Peak Health: Strengthen Scientific and Technological Innovation, Strengthen Quality Management, Accelerate Marketing Breakthrough
Aiming at several major product lines of Peak Health, the meeting called for strengthening the procurement management, quality management and production standards of health care products raw materials, strictly controlling the quality of products, speeding up the construction of health care products marketing team, formulating standardized promotion mode, speeding up marketing expansion and achieving breakthroughs; Clarify the positioning of plant products, focus on the promotion, through technological innovation, patents, the formulation of industry standards and other methods, improve the market threshold, so as to establish a leading advantage in the extract industry; traditional Chinese medicine pieces should strengthen the construction of raw material base, and small package pieces, granules and other attempts; all kinds of products should do a good job in the coordination of production and sales, and strictly control the production cost.
International Trade Company: Strengthen management, improve service quality, and expand enterprise scale
The meeting requires international trade companies to combine the actual situation of the enterprise, strengthen on-site management, eliminate management loopholes, and reduce operating costs; improve management standardization Level, improve service quality; carry out various tasks in a targeted manner, form a business model with advantages and own characteristics, and expand the business scale as soon as possible, establish industry competitive advantage.
Cable Company: Build Confidence, Prevent Risks, Build Brand
In view of the current cable market situation, the meeting asked the cadres and employees of Jianfeng Cable Company to cheer up, build confidence, pay close attention to market changes, pay attention to prevent the intellectual property risks of OEM products and the sales risks brought by raw material price fluctuations, and strengthen cost control. At the same time, strengthen technical research and strive to build independent brands and markets, increase profitability and strive for greater benefits. (this newspaper reporter)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page